Patents by Inventor Kevin Schnepp

Kevin Schnepp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tie-2 Modulators and Methods of Use
    Publication number: 20070275952
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: March 19, 2004
    Publication date: November 29, 2007
    Applicant: Exelixis, Inc.
    Inventors: Lynne Bannen, S. Brown, Wei Cheng, Vasu Jammalamadaka, John Nuss, Morrison Mac, Jason Parks, Matthew Williams, Wei Xu, Atwood Cheung, Lisa Dalrymple, Sergey Epshteyn, Mohamed Ibrahim, James Leahy, Gary Lewis, Robin Noguchi, Larry Mann, Brian Ridway, Joan Sangalang, Kevin Schnepp, Xian Shi, Richard Khoury
  • Tao Kinase Modulators And Method Of Use
    Publication number: 20070208166
    Abstract: The invention provides compounds and methods for inhibition of kinases, such as those of the TAO family, more specifically KIAA1361, TAO, and JIK kinases. The invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinase receptor signal transduction pathways related to the changes in cellular activities as mentioned above, and the invention includes compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions.
    Type: Application
    Filed: October 22, 2004
    Publication date: September 6, 2007
    Applicant: Exelixis, Inc.
    Inventors: Deborah Baly, Adam Galan, Mohamed Ibrahim, Christopher Jaeger, Patrick Kearney, James Leahy, Gary Lewis, Kirk McMillan, Robin Noguchi, John Nuss, Jason Parks, Kevin Schnepp, Xian Shi, Matthew Williams, Wei Xu, Wentao Zhang
  • Tie-2 modulators and methods of use
    Publication number: 20070161651
    Abstract: The present invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinases, particularly Tie-2. Methods of using the compounds and pharmaceutical compositions thereof to treat kinase-dependent diseases and conditions are also an aspect of the invention.
    Type: Application
    Filed: April 8, 2004
    Publication date: July 12, 2007
    Applicant: EXELIXIS, INC.
    Inventors: Mohamed Ibrahim, James Leahy, Joan Sangalang, Kevin Schnepp, Xian Shi, John Nuss